The prognostic significance of anti-angiogenesis therapy in ovarian cancer: a meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-2215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The prognostic significance of anti-angiogenesis therapy in ovarian cancer: a meta-analysis ; volume:8 ; number:1 ; day:6 ; month:8 ; year:2015 ; pages:1-10 ; date:12.2015
Journal of ovarian research ; 8, Heft 1 (6.8.2015), 1-10, 12.2015
- Creator
-
Li, Jun
Li, Shufen
Chen, Ruifang
Yu, Hailin
Lu, Xin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-015-0181-z
- URN
-
urn:nbn:de:101:1-2019112106241452582637
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Jun
- Li, Shufen
- Chen, Ruifang
- Yu, Hailin
- Lu, Xin
- SpringerLink (Online service)
Other Objects (12)
Prognostic values of S100 family members in ovarian cancer patients
Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer
Long noncoding RNA C17orf91 is a potential prognostic marker and functions as an oncogene in ovarian cancer
Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience
Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer
Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer
SCIPAC: quantitative estimation of cell-phenotype associations
The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer
Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer
The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer
Novel 3-D Macrophage Spheroid Model Reveals Reciprocal Regulation of Immunomechanical Stress and Mechano-Immunological Response
CNS tumor stroma transcriptomics identify perivascular fibroblasts as predictors of immunotherapy resistance in glioblastoma patients
Prognostic values of S100 family members in ovarian cancer patients
Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer
Long noncoding RNA C17orf91 is a potential prognostic marker and functions as an oncogene in ovarian cancer
Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience
Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer
Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer
SCIPAC: quantitative estimation of cell-phenotype associations
The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer
Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer
The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer
Novel 3-D Macrophage Spheroid Model Reveals Reciprocal Regulation of Immunomechanical Stress and Mechano-Immunological Response
CNS tumor stroma transcriptomics identify perivascular fibroblasts as predictors of immunotherapy resistance in glioblastoma patients
Prognostic values of S100 family members in ovarian cancer patients
Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer
Long noncoding RNA C17orf91 is a potential prognostic marker and functions as an oncogene in ovarian cancer
Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience
Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer
Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer
SCIPAC: quantitative estimation of cell-phenotype associations
The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer
Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer
The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer
Novel 3-D Macrophage Spheroid Model Reveals Reciprocal Regulation of Immunomechanical Stress and Mechano-Immunological Response